[{"id":"17a2e003-5254-435c-9222-116e725529ae","acronym":"","url":"https://clinicaltrials.gov/study/NCT03808558","created_at":"2021-01-18T18:49:13.553Z","updated_at":"2024-07-02T16:35:25.684Z","phase":"Phase 2","brief_title":"Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas","source_id_and_acronym":"NCT03808558","lead_sponsor":"David E Gerber","biomarkers":" EGFR • KRAS • ALK","pipe":" | ","alterations":" KRAS mutation • EGFR mutation • ALK rearrangement • KRAS exon 2 mutation • KRAS exon 12 mutation","tags":["EGFR • KRAS • ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • EGFR mutation • ALK rearrangement • KRAS exon 2 mutation • KRAS exon 12 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e denifanstat (TVB-2640)"],"overall_status":"Recruiting","enrollment":" Enrollment 34","initiation":"Initiation: 09/11/2019","start_date":" 09/11/2019","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2023-12-20"}]